Ranbaxy to market Lupin's TB drug in Africa

 According to a release issued by Ranbaxy to the BSE today, Ranbaxy will market Lupin's Akurit - a fixed dose combination - in Nigeria, Ghana, Ivory Coast, Cameroon, Algeria, Chad, Mauritania and Congo.

 "The alliance will leverage Ranbaxy's strength in global marketing and distribution network as well as strengthen Lupin's international expertise in the management of tuberculosis," the release added.